Back to Results
First PageMeta Content



January 13, 2014 Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director PLYMOUTH, Mich.--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharm
Add to Reading List

Document Date: 2014-01-13 12:24:20


Open Document

File Size: 19,15 KB

Share Result on Facebook